Oncosil Medical Ltd
ASX:OSL

Watchlist Manager
Oncosil Medical Ltd Logo
Oncosil Medical Ltd
ASX:OSL
Watchlist
Price: 1.04 AUD
Market Cap: 19.7m AUD

Operating Margin
Oncosil Medical Ltd

-1 188.7%
Current
-1 850%
Average
3.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 188.7%
=
Operating Profit
-15m
/
Revenue
1.3m

Operating Margin Across Competitors

No Stocks Found

Oncosil Medical Ltd
Glance View

OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2005-08-15. The firm is focused on unresectable locally advanced pancreatic cancer (LAPC). The firm's lead product, OncoSil, is a single-use brachytherapy internal radiation device used to deliver a pre-determined dose of beta radiation directly into cancerous tissue. The OncoSil consists of microparticles that contain a radioisotope phosphorous-32 and a formulated diluent, which acts as a carrier to facilitate the implantation of the microparticles into the target tissue. The company enables doctors to target a greater radiation dose directly to the tumor, while sparing surrounding critical organs. The OncoSil device is used for the treatment of unresectable LAPC and is used in conjunction with chemotherapy.

OSL Intrinsic Value
0.44 AUD
Overvaluation 58%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 188.7%
=
Operating Profit
-15m
/
Revenue
1.3m
What is the Operating Margin of Oncosil Medical Ltd?

Based on Oncosil Medical Ltd's most recent financial statements, the company has Operating Margin of -1 188.7%.

Back to Top